GRI Bio Stock (NASDAQ: GRI) stock price, news, charts, stock research, profile.
Open | $0.761 |
Close | $0.760 |
Volume / Avg. | 126.914K / 719.467K |
Day Range | 0.760 - 0.800 |
52 Wk Range | 0.750 - 93.310 |
Market Cap | $741.998K |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 35 |
Short Interest | 13.27% |
Days to Cover | 1 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of GRI Bio (NASDAQ: GRI) through any online brokerage.
Other companies in GRI Bio’s space includes: NeuBase Therapeutics (NASDAQ:NBSE), Dermata Therapeutics (NASDAQ:DRMA), Bone Biologics (NASDAQ:BBLG), Qualigen Therapeutics (NASDAQ:QLGN) and Cyclacel Pharmaceuticals (NASDAQ:CYCC).
There is no analysis for GRI Bio.
The stock price for GRI Bio (NASDAQ: GRI) is $0.7601 last updated March 28, 2024 at 6:32 PM EDT.
A quarterly cash dividend of $0.51 per share of Class A Common Stock. The quarterly cash dividend was payable on December 27, 2019 to stockholders of record on December 19, 2019.
GRI Bio does not have any upcoming earnings scheduled.
There is no upcoming split for GRI Bio.
GRI Bio is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.